| scholarly article | Q13442814 |
| P50 | author | Kanakeshwari Falzari | Q59316316 |
| Rheinallt M. Jones | Q44884067 | ||
| P2093 | author name string | Jerrold R Turner | |
| Gail A Hecht | |||
| V K Viswanathan | |||
| Andrew S Neish | |||
| Ki-Jong Rhee | |||
| Amy Kim | |||
| Amy Bellmeyer | |||
| Andrew W Weflen | |||
| Athanasia Koutsouris | |||
| Jennifer L Roxas | |||
| Sandhya V Royan | |||
| P2860 | cites work | A bacterial E3 ubiquitin ligase IpaH9.8 targets NEMO/IKKgamma to dampen the host NF-kappaB-mediated inflammatory response | Q22001534 |
| Bacterial effector binding to ribosomal protein s3 subverts NF-kappaB function | Q24293521 | ||
| Flagellin-dependent and -independent inflammatory responses following infection by enteropathogenic Escherichia coli and Citrobacter rodentium | Q24655784 | ||
| An extensive repertoire of type III secretion effectors in Escherichia coli O157 and the role of lambdoid phages in their dissemination | Q24678382 | ||
| Lambda Red-mediated recombinogenic engineering of enterohemorrhagic and enteropathogenic E. coli | Q24804947 | ||
| PRALINE: a multiple sequence alignment toolbox that integrates homology-extended and secondary structure information | Q24812359 | ||
| One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products | Q27860842 | ||
| Salmonella secreted factor L deubiquitinase of Salmonella typhimurium inhibits NF-kappaB, suppresses IkappaBalpha ubiquitination and modulates innate immune responses | Q50063361 | ||
| Enteropathogenic E. coli disrupts tight junction barrier function and structure in vivo. | Q53845870 | ||
| Enteropathogenic Escherichia coli (EPEC) effector-mediated suppression of antimicrobial nitric oxide production in a small intestinal epithelial model system. | Q54474693 | ||
| NF-kappaB regulation in the immune system | Q28205043 | ||
| Host-pathogen interactions: subversion and utilization of the NF-kappa B pathway during infection | Q28386446 | ||
| Exploitation of eukaryotic ubiquitin signaling pathways by effectors translocated by bacterial type III and type IV secretion systems | Q33270514 | ||
| NleH effectors interact with Bax inhibitor-1 to block apoptosis during enteropathogenic Escherichia coli infection | Q33733678 | ||
| Mouse model of enteropathogenic Escherichia coli infection | Q33792879 | ||
| The locus of enterocyte effacement (LEE)-encoded regulator controls expression of both LEE- and non-LEE-encoded virulence factors in enteropathogenic and enterohemorrhagic Escherichia coli. | Q34004916 | ||
| Enteropathogenic Escherichia coli contains a putative type III secretion system necessary for the export of proteins involved in attaching and effacing lesion formation | Q34022530 | ||
| The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes | Q34048081 | ||
| Expression of the chemokine N51/KC in the thymus and epidermis of transgenic mice results in marked infiltration of a single class of inflammatory cells | Q34325984 | ||
| Neutrophil infiltration, glial reaction, and neurological disease in transgenic mice expressing the chemokine N51/KC in oligodendrocytes | Q34392185 | ||
| Acetylation of MEK2 and I kappa B kinase (IKK) activation loop residues by YopJ inhibits signaling | Q34583187 | ||
| Flagellin of enteropathogenic Escherichia coli stimulates interleukin-8 production in T84 cells | Q34853145 | ||
| The effector repertoire of enteropathogenic E. coli: ganging up on the host cell | Q34921824 | ||
| A Salmonella enterica serovar typhimurium translocated leucine-rich repeat effector protein inhibits NF-kappa B-dependent gene expression. | Q35106240 | ||
| Infectious Infantile Enteritis, Yesterday and Today | Q35667227 | ||
| Bacterial inhibition of eukaryotic pro-inflammatory pathways | Q35794638 | ||
| Salmonella effector AvrA regulation of colonic epithelial cell inflammation by deubiquitination | Q35963199 | ||
| Enteropathogenic Escherichia coli: unravelling pathogenesis | Q36010824 | ||
| In vitro signaling by MAPK and NFkappaB pathways inhibited by Yersinia YopJ. | Q36204380 | ||
| Bacteria and the ubiquitin pathway | Q36678179 | ||
| The p50 subunit of NF-kappaB is critical for in vivo clearance of the noninvasive enteric pathogen Citrobacter rodentium | Q36949962 | ||
| Role of NleH, a type III secreted effector from attaching and effacing pathogens, in colonization of the bovine, ovine, and murine gut. | Q36950038 | ||
| Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157:H7 | Q36986374 | ||
| Tools for characterization of Escherichia coli genes of unknown function | Q39679916 | ||
| Enteropathogenic Escherichia coli (EPEC) inactivate innate immune responses prior to compromising epithelial barrier function. | Q40153854 | ||
| Balance of bacterial pro- and anti-inflammatory mediators dictates net effect of enteropathogenic Escherichia coli on intestinal epithelial cells | Q40345219 | ||
| Comparative analysis of EspF from enteropathogenic and enterohemorrhagic Escherichia coli in alteration of epithelial barrier function | Q40553631 | ||
| Cutting edge: Salmonella AvrA effector inhibits the key proinflammatory, anti-apoptotic NF-kappa B pathway. | Q40705607 | ||
| Activation of NF-kappaB in intestinal epithelial cells by enteropathogenic Escherichia coli. | Q41081300 | ||
| Complete genome sequence and comparative genome analysis of enteropathogenic Escherichia coli O127:H6 strain E2348/69. | Q41823804 | ||
| Role of NF-kappaB in immune and inflammatory responses in the gut. | Q41878721 | ||
| The type III secretion effector NleE inhibits NF-kappaB activation | Q41893338 | ||
| Distribution, functional expression, and genetic organization of Cif, a phage-encoded type III-secreted effector from enteropathogenic and enterohemorrhagic Escherichia coli. | Q41911735 | ||
| Regulation of expression and secretion of NleH, a new non-locus of enterocyte effacement-encoded effector in Citrobacter rodentium | Q42115897 | ||
| Suppression of NF-kappa B activation and proinflammatory cytokine expression by Shiga toxin-producing Escherichia coli | Q42436813 | ||
| Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses | Q42488424 | ||
| The enteropathogenic Escherichia coli effector NleH inhibits apoptosis induced by Clostridium difficile toxin B. | Q42708074 | ||
| Regulation of type III secretion hierarchy of translocators and effectors in attaching and effacing bacterial pathogens | Q42727344 | ||
| Salmonella AvrA Coordinates Suppression of Host Immune and Apoptotic Defenses via JNK Pathway Blockade | Q44884016 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Escherichia coli | Q25419 |
| NF-κB | Q411114 | ||
| enteropathogen | Q63500873 | ||
| P304 | page(s) | 1232-1245 | |
| P577 | publication date | 2010-10-15 | |
| P1433 | published in | Molecular Microbiology | Q6895967 |
| P1476 | title | Enteropathogenic E. coli non-LEE encoded effectors NleH1 and NleH2 attenuate NF-κB activation | |
| P478 | volume | 78 |
| Q41902646 | A distinct regulatory sequence is essential for the expression of a subset of nle genes in attaching and effacing Escherichia coli |
| Q27313870 | Age-Dependent Susceptibility to Enteropathogenic Escherichia coli (EPEC) Infection in Mice |
| Q37871646 | Always one step ahead: How pathogenic bacteria use the type III secretion system to manipulate the intestinal mucosal immune system |
| Q37683337 | Bacterial serine/threonine protein kinases in host-pathogen interactions |
| Q38318508 | Bringing down the host: enteropathogenic and enterohaemorrhagic Escherichia coli effector-mediated subversion of host innate immune pathways |
| Q50020373 | Cooperative Immune Suppression by Escherichia coli and Shigella Effector Proteins |
| Q39432286 | Determination of spatial and temporal colonization of enteropathogenic E. coli and enterohemorrhagic E. coli in mice using bioluminescent in vivo imaging |
| Q49358566 | EPEC NleH1 is significantly more effective in reversing colitis and reducing mortality than NleH2 via differential effects on host signaling pathways. |
| Q26991857 | Effector triggered manipulation of host immune response elicited by different pathotypes of Escherichia coli |
| Q26774700 | Elucidating Host-Pathogen Interactions Based on Post-Translational Modifications Using Proteomics Approaches |
| Q41506828 | Enteropathogenic E. coli effectors EspG1/G2 disrupt microtubules, contribute to tight junction perturbation and inhibit restoration |
| Q55605885 | Enteropathogenic Escherichia coli EspH-Mediated Rho GTPase Inhibition Results in Desmosomal Perturbations. |
| Q34177961 | Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements |
| Q91933031 | EspFu-Mediated Actin Assembly Enhances Enteropathogenic Escherichia coli Adherence and Activates Host Cell Inflammatory Signaling Pathways |
| Q28731369 | Expression and regulation of the Escherichia coli O157:H7 effector proteins NleH1 and NleH2 |
| Q34889643 | Expression of enteropathogenic Escherichia coli map is significantly different than that of other type III secreted effectors in vivo |
| Q37987493 | Flagella and bacterial pathogenicity |
| Q34263876 | Functional differences and interactions between the Escherichia coli type III secretion system effectors NleH1 and NleH2. |
| Q93075161 | Hsp90 Interacts with the Bacterial Effector NleH1 |
| Q24297066 | IKKβ phosphorylation regulates RPS3 nuclear translocation and NF-κB function during infection with Escherichia coli strain O157:H7 |
| Q40604251 | Identification of a Distinct Substrate-binding Domain in the Bacterial Cysteine Methyltransferase Effectors NleE and OspZ. |
| Q38086226 | In vitro and in vivo model systems for studying enteropathogenic Escherichia coli infections |
| Q38007348 | Infection strategies of enteric pathogenic Escherichia coli |
| Q24299272 | Inhibition of TLR signaling by a bacterial protein containing immunoreceptor tyrosine-based inhibitory motifs |
| Q35163621 | Metalloprotease NleC suppresses host NF-κB/inflammatory responses by cleaving p65 and interfering with the p65/RPS3 interaction |
| Q35108874 | Microbial strategies for antagonizing Toll-like-receptor signal transduction |
| Q28079739 | Modulation of the Inflammasome Signaling Pathway by Enteropathogenic and Enterohemorrhagic Escherichia coli |
| Q91964035 | Molecular Mechanisms That Define Redox Balance Function in Pathogen-Host Interactions-Is There a Role for Dietary Bioactive Polyphenols? |
| Q58111768 | Novel Effector Protein EspY3 of Type III Secretion System from Enterohemorrhagic Is Localized in Actin Pedestals |
| Q36911360 | Prolonged NF-κB activation by a macrophage inhibitory cytokine 1-linked signal in enteropathogenic Escherichia coli-infected epithelial cells |
| Q42860357 | Proteolytic Cleavage of NF-κB p65: A Novel Mechanism for Subversion of Innate Immune Signaling by Pathogenic E. Coli |
| Q37847232 | Recognition of bacterial pathogens and mucosal immunity. |
| Q38522801 | Role of virulence factors on host inflammatory response induced by diarrheagenic Escherichia coli pathotypes |
| Q46268393 | Structural host-microbiota interaction networks |
| Q37951705 | Subversion of innate immune responses by bacterial hindrance of NF-κB pathway |
| Q26773133 | Subverting Toll-Like Receptor Signaling by Bacterial Pathogens |
| Q36200507 | The Type III Effector NleD from Enteropathogenic Escherichia coli Differentiates between Host Substrates p38 and JNK. |
| Q38255302 | The cell death response to enteropathogenic Escherichia coli infection |
| Q28478223 | The enteropathogenic E. coli (EPEC) Tir effector inhibits NF-κB activity by targeting TNFα receptor-associated factors |
| Q39495822 | The pathogenic Escherichia coli type III secreted protease NleC degrades the host acetyltransferase p300. |
| Q34699747 | The serine phosphatase SerB of Porphyromonas gingivalis suppresses IL-8 production by dephosphorylation of NF-κB RelA/p65 |
| Q27009174 | Tyrosine phosphorylation and bacterial virulence |
Search more.